Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis

Conclusion:
Efficacy of DMF in our clinic population did not differ across three major ethnic groups, WA, AA and HA, and was comparable with results observed in the pivotal studies. These ‘real-life’ data suggest that race is not a factor that needs to be taken into account when initiating DMF.

Source: Therapeutic Advances in Neurological Disorders - October 12, 2016 Category: Neurology Authors: Zhovtis Ryerson, L., Green, R., Confident, G., Pandey, K., Richter, B., Bacon, T., Sammarco, C., Laing, L., Kalina, J., Kister, I. Tags: Original Research Source Type: research